Skip to content
healthcare.dev

Nivestym

NDC 0069-0294, filgrastim-aafi, injection, solution, from Pfizer Laboratories Div Pfizer Inc.

Product NDC
0069-0294
Status
Listed
Labeler
Pfizer Laboratories Div Pfizer Inc
Dosage form
INJECTION, SOLUTION
Route
INTRAVENOUS, SUBCUTANEOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
BLA
Application
BLA761080
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/0069-0294 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • FILGRASTIM480 ug/1.6mL

Pharmacologic classes

Granulocyte Colony-Stimulating Factor [CS]; Increased Myeloid Cell Production [PE]; Leukocyte Growth Factor [EPC]

Package NDCNDC-11Package
0069-0294-100006902941010 VIAL, SINGLE-DOSE in 1 CARTON (0069-0294-10) / 1.6 mL in 1 VIAL, SINGLE-DOSE (0069-0294-01)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/d23ab39c-b6ec-41cf-a529-9dd2852c9d9a
  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=0069-0294

Use it

Look up 0069-0294 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/0069-0294 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 0069-0294. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.